Table 2. Correlation of βLRI and LLRI scores with clinical and pathological variables.

Variables	Cases	βLRI		X2	P value	Cases	LLRI		X2	P value
		≤ 4.87	> 4.87				≤ 128.44	> 128.44
Age (years)
≤ 45	122	107 (87.7%)	15 (12.3%)	1.904	0.222	126	76 (60.3%)	50 (39.7%)	1.819	0.191
> 45	77	62 (80.5%)	15 (19.5%)			77	39 (50.6%)	38 (49.4%)
Gender
Male	140	117 (83.6%)	23 (16.4%)	0.675	0.517	144	82 (56.9%)	62 (43.1%)	0.017	1
Female	59	52 (88.1%)	7 (11.9%)			59	33 (55.9%)	26 (44.1%)
B symptoms
Yes	97	81 (83.5%)	16 (16.5%)	0.298	0.693	99	73 (70.2%)	31 (29.8%)	15.93	< 0.001
No	102	88 (86.3%)	14 (13.7%)			104	42 (42.4%)	57 (57.6%)
Ann Arbor Stage
IE	147	128 (87.1%)	19 (12.9%)	2.032	0.117	151	88 (58.3%)	63 (41.7%)	0.636	0.517
IIE	52	41 (78.8%)	11 (21.2%)			52	27 (51.9%)	25 (48.1%)
ECOG
0–1	191	164 (85.9%)	27 (14.1%)	3.274	0.102	195	112 (57.4%)	83 (42.6%)	1.244	0.297
> 1	8	5 (62.5%)	3 (37.5%)			8	3 (37.5%)	5 (62.5%)
Paranasal extension
Yes	86	70 (81.4%)	16 (18.6%)	5.940	0.023	88	42 (47.7%)	46 (52.3%)	9.657	0.003
No	61	58 (95.1%)	3 (4.9%)			63	46 (73.0%)	17 (27.0%)
Lymph Node Infiltration
Yes	45	36 (80%)	9 (20%)	1.102	0.343	45	91 (57.6%)	67 (42.4%)	0.259	0.614
No	154	133 (86.4%)	21 (13.6%)			158	24 (53.3%)	21 (46.7%)
LDH Elevated
Yes	55	43 (78.2%)	12 (21.8%)	2.699	0.121
No	144	126 (87.5%)	1812.5%)
IPI
0–1	184	161 (87.5%)	23 (12.5%)	12.65	0.002	188	110 (58.5%)	78 (41.5%)	3.586	0.101
> 1	15	8 (53.3%)	7 (46.7%)			15	5 (33.3%)	10 (66.7%)
KPI
0–1	140	125 (89.3%)	15 (10.7%)	7.015	0.010	144	92 (63.9%)	52 (36.1%)	10.571	0.002
> 1	59	44 (74.6%)	15 (25.4%)			59	23 (39.0%)	36 (61.0%)
Recurrence
0	145	129 (89%)	16 (11%)	6.815	0.014	148	88 (59.5%)	60 (40.5%)	1.755	0.205
1	54	40 (74.1%)	14 (25.9%)			55	27 (49.1%)	28 (50.9%)